279 related articles for article (PubMed ID: 19721401)
21. Mechanisms of cardioprotection by lysophospholipids.
Karliner JS
J Cell Biochem; 2004 Aug; 92(6):1095-103. PubMed ID: 15258895
[TBL] [Abstract][Full Text] [Related]
22. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.
Knapp M; Zendzian-Piotrowska M; Błachnio-Zabielska A; Zabielski P; Kurek K; Górski J
Basic Res Cardiol; 2012 Nov; 107(6):294. PubMed ID: 22961594
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.
B Gowda S; Gowda D; Kain V; Chiba H; Hui SP; Chalfant CE; Parcha V; Arora P; Halade GV
Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H599-H611. PubMed ID: 34415189
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction.
Klyachkin YM; Nagareddy PR; Ye S; Wysoczynski M; Asfour A; Gao E; Sunkara M; Brandon JA; Annabathula R; Ponnapureddy R; Solanki M; Pervaiz ZH; Smyth SS; Ratajczak MZ; Morris AJ; Abdel-Latif A
Stem Cells Transl Med; 2015 Nov; 4(11):1333-43. PubMed ID: 26371341
[TBL] [Abstract][Full Text] [Related]
25. Erythrocytes store and release sphingosine 1-phosphate in blood.
Hänel P; Andréani P; Gräler MH
FASEB J; 2007 Apr; 21(4):1202-9. PubMed ID: 17215483
[TBL] [Abstract][Full Text] [Related]
26. Letter by Xia regarding article, "High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor".
Xia P
Circulation; 2007 Apr; 115(14):e393; author reply e394. PubMed ID: 17420358
[No Abstract] [Full Text] [Related]
27. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure.
Knapp M; Baranowski M; Lisowska A; Musiał W
Adv Med Sci; 2012 Jun; 57(1):100-5. PubMed ID: 22296975
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
29. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease.
van der Giet M; Tölle M; Kleuser B
Biol Chem; 2008 Nov; 389(11):1381-90. PubMed ID: 18925828
[TBL] [Abstract][Full Text] [Related]
30. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
[TBL] [Abstract][Full Text] [Related]
31. The sphingosine 1-phosphate receptor 5 and sphingosine kinases 1 and 2 are localised in centrosomes: possible role in regulating cell division.
Gillies L; Lee SC; Long JS; Ktistakis N; Pyne NJ; Pyne S
Cell Signal; 2009 May; 21(5):675-84. PubMed ID: 19211033
[TBL] [Abstract][Full Text] [Related]
32. Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction.
Andréani P; Gräler MH
Anal Biochem; 2006 Nov; 358(2):239-46. PubMed ID: 17027903
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
34. Ceramides, sphinganine, sphingosine and acid sphingomyelinases in the human umbilical cord blood.
Knapp P; Dobrzyń A; Górski J
Horm Metab Res; 2005 Jul; 37(7):433-7. PubMed ID: 16034716
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis.
Kułakowska A; Zendzian-Piotrowska M; Baranowski M; Konończuk T; Drozdowski W; Górski J; Bucki R
Neurosci Lett; 2010 Jun; 477(3):149-52. PubMed ID: 20434523
[TBL] [Abstract][Full Text] [Related]
36. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
Polzin A; Piayda K; Keul P; Dannenberg L; Mohring A; Gräler M; Zeus T; Kelm M; Levkau B
J Mol Cell Cardiol; 2017 Sep; 110():35-37. PubMed ID: 28709768
[TBL] [Abstract][Full Text] [Related]
37. Regulation of macrophage function by sphingosine-1-phosphate.
Weigert A; Weis N; Brüne B
Immunobiology; 2009; 214(9-10):748-60. PubMed ID: 19625101
[TBL] [Abstract][Full Text] [Related]
38. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis.
Sugiura T; Dohi Y; Yamashita S; Ohte N; Ito S; Iwaki S; Hirowatari Y; Ohkawa R; Mishima Y; Yatomi Y; Kimura G; Fujii S
Coron Artery Dis; 2012 Jun; 23(4):234-8. PubMed ID: 22356865
[TBL] [Abstract][Full Text] [Related]
39. Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.
Książek M; Baranowska U; Chabowski A; Baranowski M
Cell Physiol Biochem; 2018; 45(1):67-77. PubMed ID: 29316552
[TBL] [Abstract][Full Text] [Related]
40. Altered sphingolipid metabolism in human endometrial cancer.
Knapp P; Baranowski M; Knapp M; Zabielski P; Błachnio-Zabielska AU; Górski J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):62-6. PubMed ID: 20226264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
